ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
ed in different studies classified as: duodenal carcinoid; duodenal gastroenteropancreatic (GEP) tumor; duodenal pancreatic neuroendocrine tumor (p-NET); duodenal gastrinoma; duodenal somatostatinoma; gangliocytic paraganglioma; ampullary carcinoid or somatostatinoma; argentaffin carcinoid-producing serotonin of the duodenum; psammomatous somatostatinoma; duodenal NE carcinoma, poorly differentiated and small-cell NE carcinoma of the duodenum [6] . The clinical and management aspect of duodenal gastrinomas are included in the ‘Endocrine Tumors of the Pancreas – Gastrinoma’ section and duodenal gastrinomas will only be considered in this section in comparison with the other d-NENs. Introduction Gastric neuroendocrine neoplasms (g-NENs) [1] are increasingly recognized due to expanding indications of upper gastrointestinal (UGI) endoscopy. Often silent and benign, g-NENs may, however, be aggressive when sporadic and may sometimes mimic the course of gastric adenocarcinoma. Duodenal neuroendocrine tumors (d-NENs) [2] may or may not be associated with a functional clinical syndrome. The term d-NEN includes all duodenal tumors with neuroendocrine (NE) features as determined by histological/immunohistochemical methods including positivity for NE cytosolic markers (neuron-specific enolase (NSE), PGP 9.5) or secretory vesicle proteins (chromogranin A (CgA), synaptophysin) and also frequently the presence of specific gastrointestinal (GI) hormones [3–8] . The term d-NEN in this paper refers to tumors includ- Published online: February 15, 2012 Gianfranco Delle Fave Digestive and Liver Disease Unit ‘Sapienza’ University of Rome, Sant’Andrea Hospital Via Di Grottarossa 1035–1039, IT–00189 Rome (Italy) Tel. +39 06 3377 5691, E-Mail gianfranco.dellefave @ uniroma1.it © 2012 S. Karger AG, Basel 0028–3835/12/0952–0074$38.00/0 Accessible online at: www.karger.com/nen 1
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These tumors develop as a consequence of the parietal cell loss, which leads to reduced gastric acid secretion and downstream persistent hypergastrinemia, enterochromaffin-like cell (ECL) hyperplasia, and, in a small percentage, ECL dysplasia and gastric NETs.27”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [27]
Citations
Cites
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Apoptosis. Its significance in cancer and cancer Therapy
Kerr, J. F. R., Winterford, C. M., & HARMON, B. V. (1994) · Cancer · doi:10.1002/1097-0142(19940415)73:8<2157::aid-cncr2820730821>3.0.co;2-1 · Cited by 2,135
(2011) · Hepatogastroenterology · doi:10.5754/hge11589 · Cited by 1,756
Paraganglioma of the filum terminale internum
Kamalian, N., Abbassioun, K., Amirjamshidi, A., & Shams-Shahrabadi, M. (1987) · Journal of Neurology · doi:10.1007/bf00314201 · Cited by 1,594
Report of a case and review of the literature
Kamalian, N., Abbassioun, K., Amirjamshidi, A., et al. (1987) · Cited by 1,576
THE CLASSIFICATION OF CARCINOID TUMOURS
WILLIAMS, E. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90951-6 · Cited by 885
Pavel, M., Baudin, E., Couvelard, A., Krenning, E., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B., & Salazar, R. (2012) · Neuroendocrinology · doi:10.1159/000335597 · Cited by 873
Self-citationThe Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification
KLÖPPEL, G., PERREN, A., & HEITZ, P. U. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.002 · Cited by 794
Histological Typing of Endocrine Tumours
Solcia, E., Klöppel, G., & Sobin, L. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-59655-1 · Cited by 747
Kwekkeboom, D. J., Teunissen, J. J., Bakker, W. H., Kooij, P. P., de Herder, W. W., Feelders, R. A., van Eijck, C. H., Esser, J.-P., Kam, B. L., & Krenning, E. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.066 · Cited by 657
Self-citation
Research works printed but not linked: 30
- Attanoos R, 1991, Semin Diagn Pathol, 8, 149
- Soga J, 1996, J Exp Clin Cancer Res, 15, 3
- Bordi C, 1999, Ital J Gastroenterol Hepatol, 31, S94
- Thomas RM, 1994, Cancer, 73, 2053, 10.1002/1097-0142(19940415)73:8<2053::aid-cncr2820730807>3.0.co;2-0 · DOI · Paper page
- Cattan D, 1991, Gastroenterol Clin Biol, 15, 30C
- Marignani M, 1999, Am J Gastroenterol, 94, 766
- Spinazzola AJ, 1963, Am Surg, 29, 405
- Walton GF, 1997, Am Surg, 63, 302
- Soga J, 1999, J Exp Clin Cancer Res, 18, 13
- Taccagni GL, 1986, Am J Gastroenterol, 81, 33
- Burke AP, 1990, Arch Pathol Lab Med, 114, 700
- Capella C, 1990, Hepatogastroenterology, 37, 247
- Heymann MF, 2004, Hepatogastroenterology, 51, 1367
- Soga J, 2003, J Exp Clin Cancer Res, 22, 349
- Thom AK, 1991, Surgery, 110, 1086
- Zogakis TG, 2003, Ann Surg, 238, 42
- Gibril F, 2004, Medicine, 83, 43, 10.1097/01.md.0000112297.72510.32 · DOI · Paper page
- Cohen T, 1981, Am J Gastroenterol, 75, 197
- Amano S, 1978, Acta Pathol Jpn, 28, 721
- Orbuch M, 1995, Karger, 23, 268
- Yoshikane H, 1995, Am J Gastroenterol, 90, 642
- Meijer WG, 2003, J Nucl Med, 44, 184
- Lebtahi R, 1999, J Nucl Med, 40, 1602
- Hubalewska-Dydejczyk A, 2005, Nucl Med Rev Cent East Eur, 8, 155
- Taal BG, 2005, Minerva Gastroenterol Dietol, 51, 335
- Sato T, 2005, Hepatogastroenterology, 52, 678
- Horsley GW, 1957, Surg Gynecol Obstet, 105, 417
- Thompson GB, 1985, Surgery, 98, 1054
- Yoshikane H, 1993, Gastrointest Endosc, 39, 375, 10.1016/s0016-5107(93)70109-1 · DOI
- Kwekkeboom DJ, 2005, J Nucl Med, 46, 62S
Cited by
Items 201–300 of 328
Huerta, L. D. J., Fernández, I. S., Moreno, B. S., Maldonado, D. M., de Andrés, C. I., & Díaz‐Simón, R. (2022) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13129 · Cited by 3
GASTRIC NEUROENDOCRINE TUMOR: WHEN SURGICAL TREATMENT IS INDICATED?
Filho, A. C. A., Tercioti, V., Andreollo, N. A., Ferrer, J. A. P., Neto, J. D. S. C., & Lopes, L. R. (2023) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-672020230050e1768 · Cited by 4
“The surgical technique employed may include local excision with endoscopic resection, local resection, subtotal gastrectomy, and total gastrectomy, among others 11,12,25 .”
MethodAbout a Gastric Neuroendocrine Tumor Presenting as Polymyalgia Rheumatica and Macrocytic Anemia
Manzo, C. (2016) · Journal of Clinical Case Reports · doi:10.4172/2165-7920.1000784 · Cited by 3
Giant type III well-differentiated neuroendocrine tumor of the stomach: A case report
Bellorín, O., Shuchleib, A., Halevi, A. E., Aksenov, S., & Saldinger, P. F. (2016) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2016.06.008 · Cited by 3
Neuroendocrine Neoplasms of the Stomach
Henderson‐Jackson, E., Sheikh, U., Muhammad, J., Coppola, D., & Nasir, A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3426-3_12 · Cited by 3
“important epidemiological, pathophysiological, endoscopic, and histologic differences between each type that affects prognosis, management, and follow-up [ 11 ].”
BackgroundMethodRatnayake, G. M., Srirajaskanthan, R., Luong, T. V., Gnanasegaran, G., & Toumpanakis, C. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13067 · Cited by 3
Rydzewska, G. M., Strzelczyk, J., Bednarczuk, T., Bolanowski, M., Borowska, M., Chmielik, E., Ćwikła, J. B., Fołtyn, W., Gisterek, I., Handkiewicz-Junak, D., et al. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0051 · Cited by 5
Lazaridis, N., Rimondi, A., Cahuin, R. C., Lemmers, A., Costa, D., Bucalau, A., Mandair, D., Gupta, S., Tantau, M. V., Pioche, M., et al. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70064 · Cited by 2
Duodenal neuroendocrine tumors
Alekberzade, A. V., Крылов, Н. Н., Garmanova, T., Shahbazov, R., Azari, F. S., Zuykova, K. S., & Litovchenko, E. D. (2019) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia201907187 · Cited by 2
Evaluation of quality of clinical management of neuroendocrine tumors
Bloemen, H., Kneepkens, K., Deraedt, K., Ivanova, A., Sergeant, G., Mebis, J., & der Speeten, K. V. (2022) · Cancer Innovation · doi:10.1002/cai2.41 · Cited by 3
“…the pathology reports was based on the documentation of proliferation index (Ki67), WHO classification, TNM staging (ENETS guidelines 2012 and 2016 [5 – 10, 11 – 14]) lymphangiographic invasion and This study was approved by the institutional review board and ethics committee, conform national…”
BackgroundMethodLi, K., Chen, T., Duan, B., Ji, Y., Li, J., & Xu, M.-D. (2024) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_265_24 · Cited by 2
68Ga-Somatostatin Analogue PET/CT in Neuroendocrine Tumors
Giovannini, E., Gaeta, M. C., & Ciarmiello, A. (2014) · Journal of Diagnostic Imaging in Therapy · doi:10.17229/jdit.2014-1030-006 · Cited by 2
“Recently, one study showed the high value of 68 Ga-tetraazacyclododecane tetraacetic acid-octreotate ((68)Ga-DOTATATE) PET/CT in patients who are suspected of having a NET, such that it is now recommended by the guidelines of the European Neuroendocrine Tumor Society [57].”
BackgroundInfluentialGastric neuroendocrine tumor presenting with gastrointestinal bleeding
Yuyong, T., Yinghuan, D., Liu, D., & Jirong, H. (2015) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2015.3998/2015 · Cited by 2
“6-2% of all gastric polyps identified (5,6).”
Neuroendokrine Neoplasien des gastroenteropankreatischen Systems
Musholt, T. J., & Watzka, F. (2015) · Die Gastroenterologie · doi:10.1007/s11377-015-0003-2 · Cited by 2
Sänger, P. W., & Freesmeyer, M. G. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001154 · Cited by 2
Xiao, K. B., Swierczynski, S. L., & Xiao, G. (2021) · Journal of Surgical Case Reports · doi:10.1093/jscr/rjab076 · Cited by 2
Pedunculated gastric neuroendocrine tumor: a case report
Takeda, K., Kudo, S., & Ishida, F. (2016) · Endoscopy International Open · doi:10.1055/s-0042-116489 · Cited by 1
Zeuß, D., & Marth, T. (2016) · Springer eBooks · doi:10.1007/978-3-642-54676-1_336-2 · Cited by 1
A hidden duodenal neuroendocrine tumor: A case report
Karam, K., Taha, A., Saad, M. K., Soukarieh, K., Challita, R., Amara, J., Fiani, E., & Saikaly, E. (2024) · Medical Reports · doi:10.1016/j.hmedic.2024.100135 · Cited by 1
Si, Y., Wu, H., Wang, C., Niu, Z., Wang, B., & Zhang, X. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03992-x · Cited by 1
“Therefore, the guidelines recommend open surgeries [5, 6].”
Endoscopic Resection of Duodenal Neuroendocrine Tumors in a Western Cohort
Jaben, I. L., Cole, G. G., Coté, G. A., Bj, H., & Elmunzer, B. J. (2026) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002318 · Cited by 1
Inbar-Weissman, T., Kanani, F., Osher, E., Geva, R., Orbach, L., Sagie, B., Wolf, I., Lahat, G., & Lessing, Y. (2026) · The American Surgeon · doi:10.1177/00031348261433652 · Cited by 1
Gastroenteropankreatische neuroendokrine Neoplasien (GEP-NEN)
Noé, S., & Neu, B. (2015) · Die Gastroenterologie · doi:10.1007/s11377-015-0013-0 · Cited by 1
OTSC-assistierte Resektion eines neuroendokrinen Tumors im Duodenum: Ein Fallbericht
Schempf, U., Kratt, T., Hoetker, M. S., Stüker, D., Plentz, R. R., Malek, N. P., & Goetz, M. (2015) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0034-1398898 · Cited by 1
Liu, C.-T., Chiu, Y., & Chen, Y. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.11.010 · Cited by 1
Duodenum and Small Bowel: Mucosal Neoplasias
Ponchon, T. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8292-5_9 · Cited by 1
Eltrombopag Use in Thrombocytopenia for Endoscopic Submucosal Dissection of a Gastric Carcinoid
Kolb, J. M., Kaltenbach, T. R., Martin, B. A., Rouse, R. V., & Soetikno, R. M. (2014) · ACG Case Reports Journal · doi:10.14309/crj.2014.73 · Cited by 1
Neuroendokrine Neoplasien der Bauchspeicheldrüse und des Gastrointestinaltrakts
Bergmann, F. (2013) · Der Pathologe · doi:10.1007/s00292-013-1872-0 · Cited by 1
Li, Z. (2016) · PubMed Central · doi:10.3785/j.issn.1008-9292.2016.01.03 · Cited by 1
Neuroendocrine Tumors (GastroEnteroPancreatic)
Hameed, U., Cukier, M., Hallet, J. I., Law, C., Rowsell, C. H., & Singh, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-26276-5_16 · Cited by 1
Chowdhury, A. T. M. M., He, S., Wang, R. H., Guo, D., & Li, Y. (2019) · Journal of Digestive Endoscopy · doi:10.1055/s-0039-1694299 · Cited by 2
Spindelboeck, W., Kump, P. K., Püspök, A., Koch, R., Mayerhoefer, M. E., Haug, A. R., Fritz, E., Obermayer-Pietsch, B. M., Raderer, M., & Tribl, B. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1013-4279 · Cited by 1
Duodenal carcinoid tumour – a case report
Negrean, V., Buchman, C., Perné, M.-G., Milaciu, M. V., Domşa, I., Alexescu, T., Para, I., & Orasan, O. H. (2020) · Journal of Mind and Medical Sciences · doi:10.22543/7674.71.p114118 · Cited by 1
“Symptomatic treatment is recommended depending on the functional syndrome present in secreting tumours [23].”
BackgroundZeuß, D., & Marth, T. (2015) · Springer eBooks · doi:10.1007/978-3-642-54676-1_336-1 · Cited by 1
Eine neue Brunneninschrift aus Priene
Kah, D. (2012) · Epigraphica Anatolica · Cited by 1
A rare case of duodenal neuroendocrine tumor with hepatic metastasis
Li, J., Huang, W.-F., & Zhang, J.-Y. (2021) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2021.101850 · Cited by 1
Neuroendocrine Tumors: Stomach
Wang, J., & Doherty, G. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-84737-1_26 · Cited by 1
Neuroendocrine Tumors (Gastroenteropancreatic)
Khorasani, M., Law, C. H. L., Myrehaug, S. D., Singh, S., Assal, A., Hsieh, E., Cukier, M., & Hallet, J. I. (2020) · Springer eBooks · doi:10.1007/978-3-030-48363-0_18 · Cited by 1
Chirurgie bei neuroendokrinen Neoplasien des Pankreas: State of the Art
Nießen, A., Schimmack, S. J., Billmann, F. G., & Hackert, T. (2022) · Die Chirurgie · doi:10.1007/s00104-022-01641-8 · Cited by 1
Gastrointestinal Neuroendocrine Neoplasms
Sharma, S., & Kapoor, V. K. (2022) · Indian Journal of Endocrine Surgery and Research · doi:10.5005/jp-journals-10088-11177 · Cited by 1
Neuroendocrine Tumor of the Ampulla of Vater: A Case Report
Aman, M. S., Das, B. C., Islam, A., Arefin, M., & Gupta, S. N. (2023) · Cureus · doi:10.7759/cureus.38588 · Cited by 1
“However, in the case of ampullary NENs, patients usually present with obstructive jaundice, pain, bile duct dilation, vomiting, and diarrhea [9].”
BackgroundFunatsu, N., Hara, K., Takagi, M., Onodera, A., Ueno, K., Endo, K., & Cho, H. (2023) · Surgical Case Reports · doi:10.1186/s40792-023-01725-5 · Cited by 1
“The European Neuroendocrine Tumor Society (ENETS) guidelines recommend endoscopic surveillance every 12 months in patients with tumor recurrence as the optimal form of treatment, and a surveillance every 24 months for patients with a history of NET with no current tumor recurrence [12].”
BackgroundPlotnikova, E. Y. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-467 · Cited by 1
Neuroendocrine Neoplasms of the Digestive System
Esposito, I., Klöppel, G., Esposito, I., Kasajima, A., Rosa, S. L., Dizdar, L., Knoefe, W. T., Schott, M., Dromain, C., Villard, N., et al. (2024) · Wiley eBooks · doi:10.1002/9781119756422.ch24 · Cited by 2
Fang, S., Shi, Y.-P., Wang, L., Han, S., & Shi, Y. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i3.907 · Cited by 1
“For patients with a tumour diameter ≥ 2 cm or local/distant metastasis, surgical surgery is preferred[11].”
Weyenberg, S. V., & Pohl, J. (2013) · Video Journal and Encyclopedia of GI Endoscopy · doi:10.1016/s2212-0971(13)70073-6 · Cited by 1
Gastric carcinoids escaping the currently available classification
de Mestier, L., Diébold, M.-D., Devulder, F., Picot, R., & Cadiot, G. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1010102 · Cited by 1
“In particular, Type 3 is associated with poorer differentiation, higher proliferation rate (Ki-67 index), and subsequently higher rates of metastases and tumorrelated deaths [1,2].”
BackgroundNeuroendocrine Tumors of the Gastrointestinal Tract
El-Zimaity, H. M. T. (2019) · Atlas of anatomic pathology · doi:10.1007/978-3-030-12379-6_5 · Cited by 1
O’Toole, D., Tang, L. H., Jensen, R. T., Falconi, M., Pape, U., & Kwekkeboom, D. J. (2017) · Wiley eBooks · doi:10.1002/9780471420194.tnmm50 · Cited by 1
Self-citationSomatostatin Receptor Scintigraphy in Management of Patients with Neuroendocrine Neoplasms
Sowa‐Staszczak, A., Stefańska, A., Jabrocka‐Hybel, A., & Hubalewska–Dydejczyk, A. (2015) · Wiley eBooks · doi:10.1002/9781119031659.ch9
Surgery for Pancreatic Neuroendocrine Neoplasms (pNENs)
Clerici, T., & Schmied, B. M. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2146-6_10
Lawrence, B. J., Anderson, Schimmack, Findlay, Kidd, & Modlin (2012) · Gastrointestinal Cancer Targets and Therapy · doi:10.2147/gictt.s21939
Genetic Syndromes Associated with Neuroendocrine Tumours
de Herder, W. W., & Valk, G. D. (2015) · Springer eBooks · doi:10.1007/978-3-662-45215-8_5
Joo, J. S., Kim, J., Shin, H. J., Kim, G. D., Moon, H. S., Kang, S. H., Sung, J. K., Jeong, H. Y., Kim, K., & Song, I. S. (2015) · The Korean Journal of Helicobacter and Upper Gastrointestinal Research · doi:10.7704/kjhugr.2015.15.3.192
Endoscopic resection of sporadic Type III gastric carcinoid
Ohtsu, I., Chinzei, R., Takahashi, M. P., Doi, H., Sasajima, K., & Watanabe, H. (2014) · Progress of Digestive Endoscopy · doi:10.11641/pde.85.1_78
Neuroendokrine Tumoren: Moderne nuklearmedizinische Optionen
Schmidt, M. C., Cremer, B., & Drzezga, A. E. (2014) · best practice onkologie · doi:10.1007/s11654-013-0113-6
Ishino, S., Shiraishi, M., Oshita, A., Tsutsumi, A., & Nishimaki, T. (2015) · 日本消化器外科学会雑誌 · doi:10.5833/jjgs.2014.0098
Grimaldi, F., Fazio, N., Attanasio, R., Frasoldati, A., Zini, M., Nuova, S. M., Papini, E., Angelini, F., Bianchetti, S., Baldelli, R., et al. (2014)
Neophytou, H., Mathieu, A., Monseu, M., Roblet, D., Boissonot, O., Andrieux, V., Furudoï, A., & Donatini, G. (2015) · Annales d Endocrinologie · doi:10.1016/j.ando.2015.06.002
“For peri-ampullary NETs, thus, there is a high risk of es metastasis non-related to the size of the tumour, surgiresection plus lymphadenectomy is recommended whatever size was [5].”
BackgroundInfluentialDisseminiertes neuroendokrines Zellsystem
Perren, A. A., Klöppel, G., Heitz, P. U., & Komminoth, P. (2015) · Springer eBooks · doi:10.1007/978-3-642-04566-0_23
(2015) · Oxford University Press eBooks · doi:10.1093/med/9780199689842.003.0017
Neuroendocrine Tumor Classification Systems: Grading
Seydafkan, S., & Coppola, D. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3426-3_1
Endoscopic Diagnosis of Gastrointestinal and Pancreatic Neuroendocrine Tumors
Costamagna, G., Boškoski, I., & Attili, F. (2017) · Updates in surgery/Updates in surgery series · doi:10.1007/978-88-470-3955-1_6
Kurative endoskopische Therapie: Welche Läsionen eignen sich?
Munding, J. B., & Tannapfel, A. (2017) · TumorDiagnostik & Therapie · doi:10.1055/s-0043-117149
“Eine chirurgische Therapie wird empfohlen, wenn eine Infiltration über die Submukosa hinausgeht oder eine Lymphgefäßinfiltration vorhanden ist [30].”
BackgroundInfluentialManagement of Pancreatic and Duodenal Neuroendocrine Tumors
Landoni, L., Cingarlini, S., Paiella, S., Severi, S., Miotto, M., Nessi, C., Grego, E., Sansovini, M., Carlini, M., & Bassi, C. (2017) · Updates in surgery/Updates in surgery series · doi:10.1007/978-88-470-3955-1_11
Therapy for Metastatic Disease: Stomach/Duodenum, Colon/Rectum
Tafuto, S., Divitiis, C. D., Bianco, A., Capozzi, M., Lassandro, F., Tatangelo, F., Rosa, N. D., Ottaiano, A., Bergaminelli, C., Petrillo, A., et al. (2017) · Springer eBooks · doi:10.1007/978-3-319-59024-0_20
Николаевич, В. А., Pirogov, S. S., Богданов, С. Н., Ovchinnikov, A. V., Sokolov, V. V., & Khomyakov, V. M. (2018) · Endoscopic Surgery · doi:10.17116/endoskop201824251
Gastric and Duodenal Neuroendocrine Tumours
Shabbir, A., So, J. B. Y., & Salgaonkar, H. P. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_35
Metachronous duodenal neuroendocrine neoplasms after endoscopic mucosal resection
Wang, H., Liang, C., Wu, C., Chiu, Y., Chou, Y., Wu, K., Huang, C., Chuah, S., Tai, W., & Lu, L. (2017) · Advances in digestive medicine · doi:10.1002/aid2.12071
“The ENETS recommends endoscopic treatments for G1 NETs ≦ 10 mm that do not extend beyond the submucosal layer and without lymph node metastasis.”
BackgroundTreatment of Neuroendocrine Tumour Disease
Moore, A. R., & Yip, V. S. K. (2018) · Springer eBooks · doi:10.1007/978-3-319-92216-4_20
O’Toole, D., Tang, L. H., Jensen, R. T., Falconi, M., Pape, U., & Kwekkeboom, D. J. (2015) · Wiley eBooks · doi:10.1002/9781119013143.ch52
Self-citationTransduodenal Local Resection of Ampullary Neuroendocrine Tumors with Bleeding
Ergin, A., İşcan, Y., Ağca, B., & Memışoğlu, K. (2019) · Journal of Clinical and Investigative Surgery · doi:10.25083/2559.5555/4.1/42.47
Modern approaches to the treatment of gastric neuroendocrine tumors
Николаевич, П. И., Bokhian, V., Stilidi, I. S., & Delektorskaya, V. V. (2016) · Russian Journal of Oncology · doi:10.18821/1028-9984-2016-21-3-165-168
Management of Gastric Neuroendocrine Tumors
Daşıran, M. F., & Akbaş, A. (2020) · Anadolu Kliniği Tıp Bilimleri Dergisi · doi:10.21673/anadoluklin.687259
Svistunov, A. А., Kireeva, N. V., & Osadchuk, M. A. (2017) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2017-95-4-316-321
Manekeller, S., & Kalff, J. C. (2015) · Der Onkologe · doi:10.1007/s00761-014-2869-x
Ravizza, D., & Fiori, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-72830-4_13
Treatment of NETs from Rare Origin
Betella, N., Smiroldo, V., Baldelli, R., & Lania, A. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-72830-4_16
Carcinoid Syndrome in a Patient with Duodenal Carcinoid Tumor
Saqeb, K. M. N., Sharmeen, F., & Hafiz, F. (2021) · Cancer Research Journal · doi:10.11648/j.crj.20210903.15
Time to give up traditional methods for the management of gastrointestinal neuroendocrine tumours
Yozgat, A., Kekilli, M., & Altay, M. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i29.8627 · Cited by 1
公伸, 笹., & 笠島, 敦. (2014) · 日本消化機病學會雜誌. 乙 · doi:10.11405/nisshoshi.111.2280
Approche chirurgicale personnalisée selon l’oncogénétique
Mariani, P., & Buecher, B. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0527-6_4
Sporadische und familiäre neuroendokrine Tumoren des Magens
Niederle, M. B., & Niederle, B. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-61724-3_40-1
SPECT/CT in Neuroendrocrine Tumours
Haslerud, T. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-65850-2_6
Sporadische und familiäre neuroendokrine Tumoren des Magens
Niederle, M. B., & Niederle, B. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-61724-3_40-2
Fahmy, W. F., Khokhar, H. A., Meshkat, B., Babikir, S., Azeem, B., & Tobbia, I. (2015) · Journal of Cancer Research & Therapy · doi:10.14312/2052-4994.2015-9
Manekeller, S. (2016) · Springer eBooks · doi:10.1007/978-3-662-49415-8_10
Neuroendocrine Tumor, Small Intestine
Sağol, Ö. (2017) · Encyclopedia of pathology · doi:10.1007/978-3-319-40560-5_2751
Lopes, J. M. (2017) · Encyclopedia of pathology · doi:10.1007/978-3-319-40560-5_1588
Gottlieb, K. T., & Mariño, G. (2013) · Springer eBooks · doi:10.1007/978-3-642-39118-7_3
Tratamiento laparoscópico de tres pacientes con tumores neuroendócrinos gástricos.
Vega, M. V., Barro, L., Baranov, S., Rosa, A. D., Larrosa, G., Cubas, S., Beraldo, G., & Santiago, P. (2020) · Cirugía del Uruguay/Cirugía del Uruguay · doi:10.31837/cir.urug.5.1.6
Experience in the diagnosis and treatment of multiple neuroendocrine tumor of the stomach
Маевская, Т. В., & Слободин, Ю. В. (2022) · Евразийский онкологический журнал · doi:10.34883/pi.2022.10.2.015
Сергеевна, К. Т., Livzan, M. A., & Mozgovoy, S. I. (2022) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-205-9-147-152
Sporadische und familiäre neuroendokrine Tumoren des Magens
Niederle, M. B., & Niederle, B. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-63317-5_40
Management of Type 1 Gastric Neuroendocrine Tumors Less than 10 mm in Diameter
Sung, J. K. (2023) · The Korean Journal of Helicobacter and Upper Gastrointestinal Research · doi:10.7704/kjhugr.2022.0065
Correlative Imaging in Neuroendocrine Tumors
Puranik, A. D., Prasad, S., Devi, I. D., & Prasad, V. (2023) · Wiley eBooks · doi:10.1002/9781119603627.ch17
An Unusual Cause of GI Blood Loss
Travers, P. M., & Pang, M. (2023) · ACG Case Reports Journal · doi:10.14309/crj.0000000000000992
“Endoscopic resection with close follow-up is sufficient for smaller, well-differentiated lesions, although the follow-up intervals are not well-defined.(12) There is also no current consensus regarding preferred imaging modalities to rule-out of malignant disease.”
BackgroundShaheen, J., Laham, O. A., Basha, Z. I., Atia, F., Aldeen, R. S., Isaac, M., & Alhanwt, A. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000459
“ing a diagnosis where chromogranin A and synaptophysin are the main stains used for G-NETs([38]).”
BackgroundÔta, H., Yokoyama, S., Yanagawa, K., Iio, S., & Fukunaga, M. (2023) · International Cancer Conference Journal · doi:10.1007/s13691-023-00624-8
Vladova, P. (2022) · Trakia Journal of Sciences · doi:10.15547/tjs.2022.04.010
Metadata
- Authors
- Delle Fave, G., Kwekkeboom, D. J., Van Cutsem, E., Rindi, G., Kos-Kudla, B., Knigge, U., Sasano, H., Tomassetti, P., Salazar, R., & Ruszniewski, P.
- Affiliations
- Hôpital Louis-Mourier (FR)
- Agostino Gemelli University Polyclinic (IT)
- Copenhagen University Hospital (DK)
- Tohoku University (JP)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Hôpital Beaujon (FR)
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2012
- Volume
- 95
- Issue
- 2
- Pages
- 74-87
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2158048233
- Cited by
- 327
- References
- 138
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 14 · 2023: 27 · 2022: 25 · 2021: 22 · 2020: 22 · 2019: 17 · 2018: 18 · 2017: 22 · 2016: 36 · 2015: 45 · 2014: 27 · 2013: 19 · 2012: 9
- FWCI
- 23.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Keywords
- neuroendocrine tumors, consensus recommendations, clinical management, gastrinoma, pancreatic neuroendocrine tumors
- MeSH terms
- Duodenal Neoplasms, Humans, Stomach Neoplasms, Neuroendocrine Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.